FI954874A - Amino(tio)eetterijohdannaisia - Google Patents
Amino(tio)eetterijohdannaisia Download PDFInfo
- Publication number
- FI954874A FI954874A FI954874A FI954874A FI954874A FI 954874 A FI954874 A FI 954874A FI 954874 A FI954874 A FI 954874A FI 954874 A FI954874 A FI 954874A FI 954874 A FI954874 A FI 954874A
- Authority
- FI
- Finland
- Prior art keywords
- thio
- amino
- ether derivatives
- derivatives
- ether
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/16—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring not being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94116223 | 1994-10-14 | ||
EP94116223 | 1994-10-14 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI954874A0 FI954874A0 (fi) | 1995-10-13 |
FI954874A true FI954874A (fi) | 1996-04-15 |
FI116385B FI116385B (fi) | 2005-11-15 |
Family
ID=8216383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954874A FI116385B (fi) | 1994-10-14 | 1995-10-13 | (R)-(-)-2-[5-(4-fluorifenyyli)-3-pyridyyli-metyyliaminometyyli]kromaani keskushermoston sairauksien hoitoa varten |
Country Status (27)
Country | Link |
---|---|
US (1) | US5767132A (fi) |
EP (2) | EP1123933A1 (fi) |
JP (1) | JP3880645B2 (fi) |
KR (1) | KR100389497B1 (fi) |
CN (1) | CN1246319C (fi) |
AT (1) | ATE210657T1 (fi) |
AU (1) | AU703637B2 (fi) |
BR (1) | BR9504379A (fi) |
CA (1) | CA2160447C (fi) |
CO (1) | CO4480021A1 (fi) |
CZ (1) | CZ292104B6 (fi) |
DE (1) | DE69524528T2 (fi) |
DK (1) | DK0707007T3 (fi) |
ES (1) | ES2169102T3 (fi) |
FI (1) | FI116385B (fi) |
HU (1) | HU227883B1 (fi) |
MX (1) | MX9504332A (fi) |
NO (1) | NO308848B1 (fi) |
PL (1) | PL181165B1 (fi) |
PT (1) | PT707007E (fi) |
RU (1) | RU2155753C2 (fi) |
SI (1) | SI0707007T1 (fi) |
SK (1) | SK283870B6 (fi) |
TR (1) | TR199501253A2 (fi) |
TW (1) | TW420664B (fi) |
UA (1) | UA45952C2 (fi) |
ZA (1) | ZA958673B (fi) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL119483A (en) * | 1995-11-06 | 1999-06-20 | American Home Prod | 2-(Aminomethyl)-3,4,7,9- tetrahydro- 2H-pyrano-2[3,3-e]indol-8-ones their derivatives and pharmaceutical compositions containing them |
EP0920306A2 (en) | 1996-07-12 | 1999-06-09 | Leukosite, Inc. | Chemokine receptor antagonists and methods of use therefor |
FR2756284B1 (fr) * | 1996-11-26 | 2000-04-28 | Adir | Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN1138761C (zh) * | 1997-02-18 | 2004-02-18 | 惠氏公司 | 4-氨基烷氧基-1,3-二氢苯并咪唑-2-酮衍生物、它们的制备方法以及它们作为多巴胺自身受体(d2)激动剂的用途 |
IL131160A0 (en) * | 1997-02-18 | 2001-01-28 | American Home Prod | 5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists |
US5990144A (en) * | 1997-02-18 | 1999-11-23 | American Home Products Corporation | 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists |
US5972958A (en) * | 1997-02-18 | 1999-10-26 | American Home Products Corporation | 4-aminoalkoxy-1,3-dihydro-benzoimidazol-2-thiones |
US6127380A (en) * | 1997-02-18 | 2000-10-03 | American Home Products Corporation | 4-aminoalkoxy-1H-benzoimidazoles |
US5922715A (en) * | 1997-02-18 | 1999-07-13 | American Home Products Corporation | 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones |
ZA981308B (en) * | 1997-02-18 | 1999-08-17 | American Home Prod | 4-aminoalkoxy-1,3-dihydro-benzoimidazol-2-thones. |
JP2001509814A (ja) * | 1997-02-18 | 2001-07-24 | アメリカン・ホーム・プロダクツ・コーポレイション | 4−アミノアルコキシ−1h−ベンゾイミダゾール誘導体、それらの調製およびそれらのドパミン自己受容体(d▲下2▼)作動薬としての使用 |
CO5011067A1 (es) * | 1997-11-03 | 2001-02-28 | Novartis Ag | Derivados de bifenilo como productos farmaceuticos, su pre- paracion y composiciones farmaceuticas que los contienen |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
FR2786767B1 (fr) * | 1998-12-02 | 2001-02-23 | Pf Medicament | Nouveaux derives de 3-alkoxybenzylamines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie |
DE19858341A1 (de) | 1998-12-17 | 2000-06-21 | Merck Patent Gmbh | Chromanderivate |
WO2000056707A1 (en) * | 1999-03-24 | 2000-09-28 | Sepracor, Inc. | Diaryl thioethers, compositions and uses thereof |
DE10005150A1 (de) * | 2000-02-07 | 2001-08-09 | Merck Patent Gmbh | Verfahren zur Herstellung von 5-Arylnicotinaldehyden |
GB0004153D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
GB0004151D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
GB0004152D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
UA73981C2 (en) * | 2000-03-10 | 2005-10-17 | Merck Patent Gmbh | (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit |
DE10029371A1 (de) * | 2000-06-20 | 2002-01-03 | Merck Patent Gmbh | Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka |
DE10044091A1 (de) | 2000-09-07 | 2002-04-04 | Merck Patent Gmbh | Chromanonderivate |
US20040014788A1 (en) * | 2000-11-14 | 2004-01-22 | Gerd Bartoszyk | Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht receptor agonists |
DE10120619A1 (de) * | 2001-04-26 | 2002-10-31 | Merck Patent Gmbh | 2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman |
CN1292749C (zh) | 2001-07-26 | 2007-01-03 | 默克专利股份有限公司 | 2-[5-(4-氟苯基)-3-吡啶基甲氨基甲基]苯并二氢吡喃及其生理学上可接受的盐的新用途 |
SE0102639D0 (sv) * | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
SE0102641D0 (sv) * | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
SE0102640D0 (sv) | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
US7618988B2 (en) * | 2001-09-19 | 2009-11-17 | Merck Patentgesellschaft | Use of substituted aminomethyl chromans |
WO2003029239A1 (en) | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
US20050014818A1 (en) * | 2001-11-09 | 2005-01-20 | Masaru Mitsuda | Process for producing optically active chroman derivative and intermediate |
GB0225548D0 (en) | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7728155B2 (en) | 2003-10-24 | 2010-06-01 | Wyeth Llc | Dihydrobenzofuranyl alkanamines and methods for using same as cns agents |
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
EA009902B1 (ru) | 2004-02-13 | 2008-04-28 | УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си | Модуляторы рецепторов андрогенов |
BRPI0509759A (pt) | 2004-04-13 | 2007-10-16 | Warner Lambert Co | moduladores de androgênio |
WO2005102990A1 (en) | 2004-04-22 | 2005-11-03 | Warner-Lambert Company Llc | Androgen modulators |
JP4874965B2 (ja) | 2004-07-08 | 2012-02-15 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲン調節剤 |
GT200600158A (es) * | 2005-04-22 | 2006-11-28 | Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2,3-dihidro-1-benzofurano-2-il]metil}amina | |
AR056320A1 (es) * | 2005-04-22 | 2007-10-03 | Wyeth Corp | Derivados de cromano y cromeno, procesos de obtencion, composiciones farmaceuticas y usos de los mismos |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
TW200811182A (en) | 2006-05-25 | 2008-03-01 | Wyeth Corp | Oxindoledioxans, synthesis thereof, and intermediates thereto |
MX341847B (es) | 2011-04-19 | 2016-09-05 | Integrative Res Laboratories Sweden Ab | Moduladores novedosos de neurotransmision cortical dopaminergica y glutamatergica mediada por receptor de n-metil-d-aspartato. |
EP3297990A4 (en) * | 2015-03-26 | 2019-01-23 | The Florey Institute Of Neuroscience And Mental Health | MODULATORS OF SODIUM CHANNELS |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2364685C3 (de) * | 1973-12-27 | 1978-06-15 | Beiersdorf Ag, 2000 Hamburg | Phenoxyäthylamine |
FR2397417A1 (fr) * | 1977-07-12 | 1979-02-09 | Parcor | Procede de preparation de derives de la thienopyridine |
JPS55124742A (en) * | 1979-03-20 | 1980-09-26 | Kyowa Hakko Kogyo Co Ltd | Novel aminoalcohol derivative |
CA1337429C (en) * | 1983-12-05 | 1995-10-24 | Guy Rosalia Eugene Van Lommen | Derivatives of 2,2'-iminobisethanol |
DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
DE4135474A1 (de) * | 1991-10-28 | 1993-04-29 | Bayer Ag | 2-aminomethyl-chromane |
SI9300097B (en) * | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
JPH05255302A (ja) * | 1992-03-09 | 1993-10-05 | Yamanouchi Pharmaceut Co Ltd | 新規なクロマニルオキシアルキルアミン誘導体 |
DE4226527A1 (de) * | 1992-08-11 | 1994-02-17 | Merck Patent Gmbh | 1,4-Benzodioxanderivate |
ATE256130T1 (de) * | 1993-08-19 | 2003-12-15 | Janssen Pharmaceutica Nv | Gefässverengende dihydrobenzopyranderivate |
-
1995
- 1995-10-06 SI SI9530574T patent/SI0707007T1/xx unknown
- 1995-10-06 DE DE69524528T patent/DE69524528T2/de not_active Expired - Lifetime
- 1995-10-06 EP EP01109746A patent/EP1123933A1/en not_active Withdrawn
- 1995-10-06 DK DK95115779T patent/DK0707007T3/da active
- 1995-10-06 AT AT95115779T patent/ATE210657T1/de active
- 1995-10-06 ES ES95115779T patent/ES2169102T3/es not_active Expired - Lifetime
- 1995-10-06 EP EP95115779A patent/EP0707007B1/en not_active Expired - Lifetime
- 1995-10-06 PT PT95115779T patent/PT707007E/pt unknown
- 1995-10-11 SK SK1266-95A patent/SK283870B6/sk not_active IP Right Cessation
- 1995-10-11 BR BR9504379A patent/BR9504379A/pt not_active Application Discontinuation
- 1995-10-12 AU AU34218/95A patent/AU703637B2/en not_active Ceased
- 1995-10-12 MX MX9504332A patent/MX9504332A/es unknown
- 1995-10-12 CA CA002160447A patent/CA2160447C/en not_active Expired - Fee Related
- 1995-10-12 TR TR95/01253A patent/TR199501253A2/xx unknown
- 1995-10-12 CZ CZ19952661A patent/CZ292104B6/cs not_active IP Right Cessation
- 1995-10-13 KR KR1019950035240A patent/KR100389497B1/ko not_active IP Right Cessation
- 1995-10-13 PL PL95310932A patent/PL181165B1/pl not_active IP Right Cessation
- 1995-10-13 ZA ZA958673A patent/ZA958673B/xx unknown
- 1995-10-13 CO CO95048279A patent/CO4480021A1/es unknown
- 1995-10-13 FI FI954874A patent/FI116385B/fi not_active IP Right Cessation
- 1995-10-13 CN CNB951184857A patent/CN1246319C/zh not_active Expired - Fee Related
- 1995-10-13 JP JP29056195A patent/JP3880645B2/ja not_active Expired - Lifetime
- 1995-10-13 NO NO954080A patent/NO308848B1/no not_active IP Right Cessation
- 1995-10-13 HU HU9502976A patent/HU227883B1/hu unknown
- 1995-10-13 RU RU95118105/04A patent/RU2155753C2/ru not_active IP Right Cessation
- 1995-10-13 UA UA95104511A patent/UA45952C2/uk unknown
- 1995-10-16 US US08/543,727 patent/US5767132A/en not_active Expired - Lifetime
- 1995-11-24 TW TW084112553A patent/TW420664B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO954080L (no) | Amino(tio)eterderivater | |
AU1642795A (en) | Substituted pyridylpyrazoles | |
ES2181853T3 (es) | Tratamiento del tinnitus empleando agentes neuroprotectores. | |
AU9281198A (en) | Benzofuran derivatives | |
DE69511424T2 (de) | Antifungale sordaridinderivate | |
NO175819C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-(RS)-substituerte 2,3-dihydro-5-oksy-4,6,7-trimetylbenzofuraner | |
EP1000923A4 (en) | CYCLOPENTEN DERIVATIVES | |
ATE156486T1 (de) | Fungizide 3,4-diaryl-(5h)-furan-2-onederivate | |
DK0625520T3 (da) | Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet | |
DK0466662T3 (da) | 6,7-Disubstituerede-2-aminotetraliner, der er aktive som immunmodulatorer, samt farmaceutiske præparater indeholdende sådanne forbindelser | |
FI921475A (fi) | 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur. | |
ATE242227T1 (de) | Tetrahydrofuranderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 116385 Country of ref document: FI |
|
MA | Patent expired |